from Reuters: Business News https://ift.tt/2U26W4y
Friday, March 29, 2019
AstraZeneca in cancer drug deal that could pay Daiichi Sankyo up to $6.9 billion
AstraZeneca Plc and Daiichi Sankyo Co Ltd signed a deal to develop and sell Daiichi's cancer drug trastuzumab deruxtecan that could see the British drugmaker pay as much as $6.9 billion to its Japanese partner.
from Reuters: Business News https://ift.tt/2U26W4y
from Reuters: Business News https://ift.tt/2U26W4y
Related Posts:
US Senate approves tax bill, sends it back to House for final vote- Chinese tiremaker picks North Carolina site for major plant
- New York Islanders may be returning from city to suburbs
- The Latest: Senate passes tax bill, sending it back to House
- Senate passes 1st major rewrite of US tax code in 31 years, setting stage for final House vote on Wednesday
0 comments:
Post a Comment